NEW

Masimo Announces iSirona Connectivity Hub

Masimo has announced the global launch of iSirona, a compact, versatile connectivity hub designed to maximize interoperability across the continuum of care.

DJO Acquires Trilliant Surgical

DJO LLC, a global provider of medical technologies to get and keep people moving, has announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants.

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE Total Knee System

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Arch Therapeutics, Inc. AC5 Surgical Hemostatic Device

The AC5 Surgical Hemostatic Device (AC5 ) is a peptide nanofiber scaffold designed to achieve hemostasis in laparoscopic and open surgical procedures. The time to hemostasis with AC5 is measured typically in 15 to 30 seconds. It is also being designed to conform to irregular wound geometry, to allow for normal healing and to help maintain a clear field of vision in the wound area during surgery. When squirted or sprayed onto a wound, the clear, transparent liquid intercalates into the nooks and crannies of the connective tissue where it self-assembles itself into a lattice-like gel. AC5 is currently in clinical trials and not yet available for purchase in the United States.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X